News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lupin Ltd. (LUPN.BO) Purchases Instem Preclinical Software for Novel Drug Discovery & Development Program


5/1/2012 10:46:30 AM

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Lupin Limited (Lupin) has purchased the Provantis® preclinical software solution. Provantis will be deployed at the Lupin Research Park, the company’s state-of-the art global R&D hub in Pune, India, housing over 1,000 scientists.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES